The board paper for a nuclear medicine department usually contains one number. This sets out the five things underneath it that decide whether that number holds: case mix, referral catchment, isotope logistics, staffing and utilisation.
A board paper proposing a nuclear medicine department almost always contains one number: a payback period. It is nearly always presented as a property of the equipment, and it is not. It is a property of the hospital that buys the equipment. Two hospitals in Dhaka can install the same camera in the same month and reach very different positions in year three, and none of the difference will be attributable to the camera. What follows is what actually sits underneath that number.
Bangladesh has a population of 170 million and approximately 25 to 30 functional nuclear medicine departments, almost all concentrated in Dhaka and Chittagong. The global benchmark is approximately one nuclear medicine camera per 500,000 population. Bangladesh is operating at roughly one per 7 million. This is not a demand problem. Oncology, cardiology and endocrinology referrals for SPECT and bone scans far exceed the capacity that exists. The constraint is capital investment and the perceived complexity of BAERA licensing.
That gap is the reason the investment case is usually favourable. It is also the reason the case is usually built too casually, because when a market is that underserved it is easy to assume the patients will simply arrive.
The primary revenue streams for a nuclear medicine department are whole-body bone scans, which are the highest-volume procedure, myocardial perfusion imaging for cardiology, thyroid scans and uptake studies, and renal scans. In Bangladesh, private hospital charges for these procedures range from BDT 8,000 to BDT 25,000 per study.
| Procedure | Typical charge (BDT) | Studies/month (conservative) | Monthly revenue (BDT) |
|---|---|---|---|
| Whole-body bone scan | 12,000 | 60 | 720,000 |
| Myocardial perfusion imaging | 22,000 | 30 | 660,000 |
| Thyroid scan and uptake | 8,000 | 40 | 320,000 |
| Renal scan (DTPA/DMSA) | 10,000 | 20 | 200,000 |
| Other (lung, liver, brain) | 12,000 | 15 | 180,000 |
| <strong>Total</strong> | <strong>165</strong> | <strong>2,080,000</strong> |
Read the table above again and notice where the money is. Bone scans carry the volume; myocardial perfusion carries the value per study. A department whose parent hospital has a strong oncology service will fill its bone scan list quickly and take longer to build cardiac volume. A hospital built around a busy cardiology unit with a functioning stress laboratory will do the opposite, and will reach a higher revenue per study earlier.
This matters at specification stage, not afterwards. A department that expects to be cardiac-heavy is buying different acquisition capability, different collimators and a different room layout from one that expects to be oncology-heavy. Work out your likely case mix from the referral book you already have, procedure by procedure, before the equipment specification is written. The most expensive mistake in this vertical is not overpaying for a camera. It is buying a camera configured for the department you imagined rather than the one your referrals will produce.
Nuclear medicine has almost no self-referral. Every study on the list arrives because a physician somewhere decided to order it, which means volume is a function of how many ordering physicians know the service exists, trust the report, and get the result back in time to act on it.
A gamma camera scans patients. A nuclear medicine department schedules radioactivity, and the two are not the same thing. Technetium-99m is eluted from a generator whose activity falls day by day, which means the department's realistic throughput is highest immediately after the generator arrives and lowest just before the next one. Utilisation is therefore not flat across the week, and any financial model that divides monthly studies by working days is already wrong.
The practical consequences are worth spelling out. Studies get batched, so bone scan lists cluster around elution days. A generator delivery that slips by one day does not lose one day of work, it compresses a week. Imported kits and isotopes with short half-lives are exposed to customs clearance times in a way that ordinary medical consumables are not, so the clearance route needs to be established and tested before the first patient, not discovered during the first delay. Public holidays interact badly with all of this. And any therapy or specialist work using I-131, Tl-201 or Ga-67 brings its own supply chain and its own scheduling constraints on top.
Model your revenue against elution days, not calendar days. That single change usually moves a business case more than any assumption about pricing.
A single-camera department runs on one nuclear medicine physician, two technologists and one radiopharmacist. The financial model treats that as a fixed monthly cost. In practice it is the department's largest single risk, because in Bangladesh the pool of trained nuclear medicine physicians and technologists is small, and the department stops when one of them is unavailable.
Ask the questions before commissioning rather than after. Who reports when the physician is on leave? Who elutes and dispenses when the radiopharmacist is ill? Is there a second technologist trained on the same acquisition protocols, or does the department run on one person's familiarity with the console? A hospital that has not answered those is not buying a department, it is buying a camera with a rota problem attached, and its utilisation will show it.
The main operating costs are radiopharmaceuticals, meaning the Tc-99m generator and cold kits, sourced from BAEC or imported; staff, being one nuclear medicine physician, two technologists and one radiopharmacist; and the service contract for the camera. A realistic monthly operating cost for a single-camera department is BDT 600,000 to 900,000, which yields a net operating margin of BDT 1.1 to 1.5 million per month at the conservative revenue assumption above.
Two lines within that deserve attention when the quotations come in. Radiopharmaceutical cost moves with dose protocol, so a system that permits reduced administered activity changes a recurring cost, not a one-off one. And the service contract is the line most often traded away to win a tender. Confirm what it covers, what the response time is, whether a local engineer attends, and what happens to detector or electronics failures that are outside it, because an uncovered fault on a single-camera department is a month of lost revenue, not a repair bill.
A complete nuclear medicine department setup, including the SPECT/CT camera, shielding, hot lab, dose calibrator, thyroid uptake probe and BAERA licensing, costs approximately BDT 80 to 140 million depending on camera specification. At a net operating margin of BDT 1.2 million per month, the payback period is 5.5 to 9.7 years. That is comparable to MRI and CT investments, with significantly lower competition in the Bangladesh market.
The range from 5.5 years to 9.7 years is not a rounding allowance. It is the whole argument. Everything above, case mix, catchment, isotope scheduling and staffing, determines where inside that band a given hospital lands, and so does utilisation in the narrow sense: how many hours a day the room is open, whether a second shift is viable, how much downtime the service contract actually prevents, and how quickly a fault is attended. A department running eight hours a day with a same-week service response sits at one end of that band. A department running five hours a day and waiting for an engineer to fly in sits at the other, with identical equipment.
All nuclear medicine facilities in Bangladesh require a licence from the Bangladesh Atomic Energy Regulatory Authority (BAERA), the national regulator constituted separately from the Bangladesh Atomic Energy Commission under the Atomic Energy Regulatory Act of 2012. BAEC is an operator and a supplier, not the licensing body, and applications sent to it are applications sent to the wrong address. The licensing process covers facility design approval, radiation shielding assessment, equipment commissioning and staff qualification verification. It is a sequence with dependencies, which is why it belongs on the project programme rather than in a paragraph at the end of the business case: shielding cannot be assessed before the layout is fixed, and commissioning cannot happen before staff qualification is in order. Vvon Technologies supports our hospital clients through the BAERA licensing process, from initial facility design through to commissioning certificate, though the licence itself is held by the hospital and the application is made in its name.